Comparison of the Mean Duration of 3rd Stage of Labour between Intraumbilical and Intravenous Oxytocin
Journal of The Society of Obstetricians and Gynaecologists of Pakistan · 18.04.2026 · 16 (2)
DOI: 10.71104/jsogp.v16i2.1046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of The Society of Obstetricians and Gynaecologists of Pakistan, online erschienen am 18.04.2026. Verfasst von Anam Javed und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective: To compare the mean duration of third stage of labour (TSL) between intraumbilical (IU) and intravenous (IV) oxytocin. Methodology: This randomized controlled trial was conducted at the Department of Obstetrics and Gynecology, Sadiq Abbasi Hospital, Bahawalpur, Pakistan, from October 2024 to March 2025. One hundred women aged 18–40 years with term singleton pregnancies and spontaneous vaginal delivery were enrolled and randomly allocated to receive either IU (10 U in 10 mL saline) or IV oxytocin (20 U in 500 mL saline). Data were analyzed using SPSS version 26.0, with group comparisons performed using appropriate statistical tests, considering p
Zitieren
APA
Javed, A., & Nadeem, S. (2026). Comparison of the Mean Duration of 3rd Stage of Labour between Intraumbilical and Intravenous Oxytocin. Journal of The Society of Obstetricians and Gynaecologists of Pakistan, 16(2). https://doi.org/10.71104/jsogp.v16i2.1046
Vancouver
Javed A, Nadeem S. Comparison of the Mean Duration of 3rd Stage of Labour between Intraumbilical and Intravenous Oxytocin. Journal of The Society of Obstetricians and Gynaecologists of Pakistan. 2026;16(2). doi:10.71104/jsogp.v16i2.1046
BibTeX
@article{Javed2026,
author = {Javed, Anam and Nadeem, Saba},
title = {Comparison of the Mean Duration of 3rd Stage of Labour between Intraumbilical and Intravenous Oxytocin},
journal = {Journal of The Society of Obstetricians and Gynaecologists of Pakistan},
year = {2026},
volume = {16},
number = {2},
doi = {10.71104/jsogp.v16i2.1046}
}
EUVIMED